{"log_id": 2821824257391296469, "direction": 0, "words_result_num": 27, "words_result": [{"probability": {"variance": 0, "average": 0.99981, "min": 0.9996}, "location": {"width": 115, "top": 234, "height": 27, "left": 214}, "words": "化学结构式"}, {"probability": {"variance": 0.055022, "average": 0.74354, "min": 0.508972}, "location": {"width": 105, "top": 466, "height": 26, "left": 562}, "words": " H COH"}, {"probability": {"variance": 0, "average": 1, "min": 1}, "location": {"width": 43, "top": 493, "height": 22, "left": 579}, "words": " c-c"}, {"probability": {"variance": 0, "average": 0.561243, "min": 0.561243}, "location": {"width": 104, "top": 512, "height": 28, "left": 531}, "words": " HOCH"}, {"probability": {"variance": 0.01247, "average": 0.956279, "min": 0.497121}, "location": {"width": 298, "top": 630, "height": 26, "left": 213}, "words": "分子式:C19H30N5O10P·C4H4O"}, {"probability": {"variance": 0.000184, "average": 0.993882, "min": 0.953823}, "location": {"width": 150, "top": 680, "height": 26, "left": 212}, "words": "分子量:635.52"}, {"probability": {"variance": 0, "average": 0.999105, "min": 0.998838}, "location": {"width": 55, "top": 732, "height": 27, "left": 212}, "words": "性状"}, {"probability": {"variance": 0.002084, "average": 0.976665, "min": 0.885375}, "location": {"width": 152, "top": 732, "height": 45, "left": 816}, "words": "业务专用章"}, {"probability": {"variance": 0.004341, "average": 0.984414, "min": 0.597407}, "location": {"width": 803, "top": 781, "height": 29, "left": 213}, "words": "本品为白色杏仁状薄膜衣片,一面上刻有“ GILEAD”,下刻有“43312。除去包衣"}, {"probability": {"variance": 1e-06, "average": 0.99879, "min": 0.997106}, "location": {"width": 88, "top": 813, "height": 25, "left": 214}, "words": "后显白色"}, {"probability": {"variance": 0, "average": 0.999186, "min": 0.998598}, "location": {"width": 68, "top": 865, "height": 24, "left": 220}, "words": "适应症"}, {"probability": {"variance": 0.020848, "average": 0.904766, "min": 0.566456}, "location": {"width": 104, "top": 917, "height": 26, "left": 220}, "words": "HIV.1感染"}, {"probability": {"variance": 0.000832, "average": 0.993557, "min": 0.819646}, "location": {"width": 820, "top": 963, "height": 29, "left": 214}, "words": "富马酸替诺福韦二吡呋酯适用于与其他抗逆转录病毒药物联用,治疗成人HV-1感染"}, {"probability": {"variance": 0.001336, "average": 0.989686, "min": 0.816484}, "location": {"width": 681, "top": 1015, "height": 28, "left": 213}, "words": "使用富马酸替诺福韦二吡呋酯开始治疗HIV-1感染时,应考虑以下几点"}, {"probability": {"variance": 1.5e-05, "average": 0.997885, "min": 0.982014}, "location": {"width": 746, "top": 1044, "height": 27, "left": 211}, "words": "富马酸替诺福韦二吡呋酯不应与含有替诺福韦的固定剂量复方制剂联用,包括"}, {"probability": {"variance": 0.000432, "average": 0.988288, "min": 0.90973}, "location": {"width": 428, "top": 1073, "height": 27, "left": 279}, "words": "依非韦伦/恩曲他滨/富马酸替诺福韦二吡呋酯"}, {"probability": {"variance": 0.006791, "average": 0.970161, "min": 0.672832}, "location": {"width": 427, "top": 1101, "height": 27, "left": 280}, "words": "利匹韦林/恩曲他滨/富马酸替诺福韦二吡呋酯"}, {"probability": {"variance": 0.003863, "average": 0.974208, "min": 0.785723}, "location": {"width": 520, "top": 1129, "height": 26, "left": 281}, "words": "艾维雷韦/克比司特/恩曲他滨/富马酸替诺福韦二吡呋酯"}, {"probability": {"variance": 8.3e-05, "average": 0.996289, "min": 0.972209}, "location": {"width": 180, "top": 1159, "height": 25, "left": 279}, "words": "恩曲他滨替诺福韦"}, {"probability": {"variance": 1e-06, "average": 0.999208, "min": 0.997772}, "location": {"width": 135, "top": 1186, "height": 26, "left": 214}, "words": "慢性乙型肝炎"}, {"probability": {"variance": 0.005234, "average": 0.984597, "min": 0.584712}, "location": {"width": 671, "top": 1233, "height": 28, "left": 259}, "words": "富马酸替诺福韦二吡呋酯适用于治疗慢性乙肝成人和≥12岁的儿童患者"}, {"probability": {"variance": 9e-06, "average": 0.998352, "min": 0.987554}, "location": {"width": 701, "top": 1283, "height": 29, "left": 259}, "words": "在开始使用富马酸替诺福韦二吡呋酯治疗HBV感染时,应考虑到以下要点"}, {"probability": {"variance": 0, "average": 0.971595, "min": 0.971595}, "location": {"width": 43, "top": 1282, "height": 47, "left": 1009}, "words": "药"}, {"probability": {"variance": 1.7e-05, "average": 0.99751, "min": 0.981997}, "location": {"width": 721, "top": 1330, "height": 31, "left": 303}, "words": "成人患者中该适应症的确立基于从初次接受核苷治疗的受试者和既往接受过"}, {"probability": {"variance": 8e-06, "average": 0.998487, "min": 0.985737}, "location": {"width": 720, "top": 1359, "height": 29, "left": 303}, "words": "治疗且证实拉米夫定耐药的受试者中获得的安全性和疗效数据。受试者为肝"}, {"probability": {"variance": 2.4e-05, "average": 0.997043, "min": 0.978086}, "location": {"width": 549, "top": 1388, "height": 33, "left": 303}, "words": "功能代偿的 Hbeag阳性和 Hbeag阴性慢性乙肝成人受试者"}, {"probability": {"variance": 0, "average": 0.918233, "min": 0.918233}, "location": {"width": 52, "top": 1431, "height": 51, "left": 1063}, "words": "它"}], "language": 3}